A detailed history of Xtx Topco LTD transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Xtx Topco LTD holds 25,198 shares of DVAX stock, worth $319,006. This represents 0.02% of its overall portfolio holdings.

Number of Shares
25,198
Previous 16,357 54.05%
Holding current value
$319,006
Previous $183,000 53.01%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.05 - $11.61 $88,852 - $102,644
8,841 Added 54.05%
25,198 $280,000
Q2 2024

Aug 12, 2024

BUY
$10.73 - $12.58 $175,510 - $205,771
16,357 New
16,357 $183,000
Q4 2022

Feb 14, 2023

BUY
$10.27 - $13.29 $169,578 - $219,444
16,512 New
16,512 $175,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.6B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.